|
Overview
Sepsis with acute organ dysfunction,
also known as severe sepsis, is the number one cause of death in
the noncoronary intensive care unit. Today, more than 750,000 Americans
develop severe sepsis each year, equaling more than 2,000 new cases
per day in the United States. Progression of sepsis can lead to
organ dysfunction and ultimately death.
In the past, sepsis was considered to represent a
systemic inflammatory response to the presence of a presumed bacterial
infection. In light of recent research, however, sepsis has been
found to more than just inflammation. In fact, recent advances in
the diagnosis and management of the patient with severe sepsis have
been developed. Our guest today, Curtis N. Sessler, MD, FCCP, FCCM
will help give us a better understanding of these recent innovations
in severe sepsis so that they can be implemented with our clinical
practice.
Learning Objectives
Upon completion of this course, you will be able to:
-
Describe therapeutic interventions in patients
with severe sepsis based upon evidence from recent trials
-
Understand the pathophysiology of sepsis
-
Define the diagnostic criteria for sepsis
Target Audience
This CME activity is beneficial for physicians specializing in cardiopulmonary and critical care medicine and other healthcare providers who manage patients with severe sepsis.
Learner Participation to Earn Credit
-
Review the course material
-
Complete the online post-test with a score of
70% or higher
-
Complete online program evaluation
Faculty Disclosures
Curtis N. Sessler, MD, FCCP, FCCM [BioSketch]
Professor of Medicine, Virginia Commonwealth University; Medical
Director, Critical Care, Medical College of Virginia Hospitals,
Richmond, VA
Disclosure: Speakers bureau: Eli Lilly and Company.
|
|
Accreditation Statement
The American College of Chest Physicians (ACCP)
is accredited by the Accreditation Council for Continuing Medical
Education to provide Continuing Education for Physicians. The ACCP
takes responsibility for content, quality, and scientific integrity
of the CME activity.
CME Credit
The ACCP designates this educational activity
for a maximum of 1 category 1 credit toward the AMA Physician's
Recognition Award. Each physician should claim only those credits
that he/she actually spent in the activity.
Only US licensed physicians will
be awarded AMA PRA category 1 credit. All others, including international
licensed physicians, will receive a certificate of course completion.
Accreditation Period
This program was initially published on April
28, 2003 and is eligible for credit through December 31, 2004.
Disclaimer
As a sponsor accredited by ACCME, the ACCP must ensure balance,
independence, objectivity, and scientific rigor in all its individually
sponsored and jointly sponsored educational activities. All faculty
participating in this activity are expected to disclose to the activity
audience any or no significant financial interest or other relationship
(1) with the manufacturer(s) of any commercial product(s) and/or
provider(s) of commercial services discussed in an educational presentation,
and/or (2) with any commercial supporters of the activity. It remains
for the audience to determine whether the speaker's interests or
relationships may influence the presentation with regard to exposition
or conclusion. Disclosure of any or no relationships will be made
available during this activity.
|